Volume 221, Issue 8 | The Medical Journal of Australia

Editor's choice

Setting targets, measuring costs, tracking health outcomes and learning lessons

Virginia Barbour

Med J Aust 2024; 221 (8): 401-401 Free

Perspective

30/60/90 National stroke targets and stroke unit access for all Australians: it's about time

Timothy J Kleinig and Lisa Murphy, For the 30/60/90 National Stroke Targets Taskforce

Med J Aust 2024; 221 (8): 402-406 Open Access

Towards evidence‐based skin checks

Linda K Martin, Pascale Guitera, Georgina V Long, Richard A Scolyer and Anne E Cust

Med J Aust 2024; 221 (8): 407-409 Open Access

Implementability and impact in clinical research and the role of clinical trial networks

Helena J Teede, Karen Best, Frank H Bloomfield, Alan Cass, Paul Cohen, Sue Crengle, Tiffany Harris‐Brown, Stephen Jan, David W Johnson, Samantha Keogh, Anne McKenzie, Philippa Middleton, Sandra Peake, Hashim Periyalil, Paul A Scuffham, Angela Scheppokat, Greg R Sharplin and Steve Webb

Med J Aust 2024; 221 (8): 410-413 Open Access

Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context

Narcyz Ghinea

Med J Aust 2024; 221 (8): 414-416 Open Access

Ethics and law

Aligning legislation with clinical practice: off‐label prescribing under the microscope

Narcyz Ghinea

Med J Aust 2024; 221 (8): 417-419 Open Access

Erratum

Med J Aust 2024; 221 (8): 419-419 Free

Editorial

Harming those we intend to help: hospital‐acquired complications in patients with dementia

Emily H Gordon and Ruth E Hubbard

Med J Aust 2024; 221 (8): 420-421 Free

Research

The likelihood of hospital‐acquired complications in older people with dementia: a matched cohort study

Danielle Ní Chróinín, Vicki Deane, Rinsy Pulikotil Zachariah, Katrina Stott, Bernadette Shepherd, Margaret Perkins, Leesa Giang, Rozina Shekhar, Vaulina Vueti, Mandana Mayahi‐Neysi, Amy Montgomery, Kaye Rolls and Steven A Frost

Med J Aust 2024; 221 (8): 422-425 Open Access

Lessons learnt from the first two SARS‐CoV‐2 Omicron waves of the COVID‐19 pandemic in six remote Aboriginal and Torres Strait Islander communities in Queensland, Australia: a retrospective epidemiological review

Allison Hempenstall, Barbara Telfer, Sean Cowley, Shalomie Shadrach, Caroline Taunton, Jay Short, Nicolas Smoll, Roy Rasalam, Oscar Whitehead, Peter Roach, Karen Koko, Josh Stafford, Rittia Matysek, Renarta Whitcombe, Gulam Khandaker, Jason King, Nishila Moodley, Maree Finney, Rica Lacey, Steven Donohue, Richard Gair and Katie Panaretto

Med J Aust 2024; 221 (8): 426-433 Open Access

Research letter

An outbreak of reactive infectious mucocutaneous eruption (RIME) after Mycoplasma pneumoniae infections in Sydney, 2024: retrospective case series

Joseph Joseph, Kelvin Truong, Artiene Tatian and Orli Wargon

Med J Aust 2024; 221 (8): 434-435 Open Access

A rise in Mycoplasma pneumoniae respiratory infections in Victoria in late 2023 and early 2024 detected at two major testing laboratories

Maryza Graham, Thomas Tran, Changxu Zhang, Michelle Sam, Andrew Daley, Kathy Jackson and Chuan Kok Lim

Med J Aust 2024; 221 (8): 436-437 Open Access

Guideline summary

Recommendations from the 2024 Australian evidence‐based guideline for unexplained infertility: ADAPTE process from the ESHRE evidence‐based guideline on unexplained infertility

Michael F Costello, Robert J Norman, Luk Rombauts, Cynthia M Farquhar, Lisa Bedson, Marlene Kong, Clare V Boothroyd, Rebecca Kerner, Rhonda M Garad, Trudy Loos, Madeline Flanagan, Ben W Mol, Aya Mousa, Daniela Romualdi, Baris Ata, Ernesto Bosch, Samuel Santos‐Ribeiro, Ksenija Gersak, Roy Homburg, Nathalie Le Clef, Mina Mincheva, Terhi Piltonen, Sara Somers, Sesh K Sunkara, Harold Verhoeve and Helena J Teede, For the Australian NHMRC Centre for Research Excellence in Reproductive Life UI Guideline Network and the ESHRE guideline group for unexplained infertility

Med J Aust 2024; 221 (8): 438-446 Open Access

Letter to the editor

Planetary care is good cancer care

Nikki Burdett and Ben Dunne

Med J Aust 2024; 221 (8): 447-447

The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022

Md Saiful Islam and Holly Seale

Med J Aust 2024; 221 (8): 447-448